Acta Neuropathologica

Papers
(The median citation count of Acta Neuropathologica is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology379
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology259
The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics205
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies204
Distribution patterns of tau pathology in progressive supranuclear palsy199
Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline194
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody191
TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis174
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease150
Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease137
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies137
Periphery and brain, innate and adaptive immunity in Parkinson’s disease121
Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology113
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas110
APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease109
Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains107
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina106
Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation97
Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-160795
Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study92
The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models90
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change80
Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-1976
Tau strains shape disease75
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function75
Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system74
Brain arteriolosclerosis74
Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis72
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology72
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy70
The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer’s disease66
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease64
Lesion stage-dependent causes for impaired remyelination in MS64
Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol62
Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts61
Analyzing microglial phenotypes across neuropathologies: a practical guide59
The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson’s disease brain as revealed by multicolor STED microscopy57
The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis57
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma53
Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme53
Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis52
Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter52
Evidence of distinct α-synuclein strains underlying disease heterogeneity52
Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease51
Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential51
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis49
TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons49
Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders47
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition46
Interleukin-1 promotes autoimmune neuroinflammation by suppressing endothelial heme oxygenase-1 at the blood–brain barrier45
Structure of Tau filaments in Prion protein amyloidoses44
Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export43
Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology43
SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer’s disease42
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource42
The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer’s disease42
White matter microglia heterogeneity in the CNS42
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases41
Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex41
Biological sex and DNA repair deficiency drive Alzheimer’s disease via systemic metabolic remodeling and brain mitochondrial dysfunction41
Infratentorial IDH-mutant astrocytoma is a distinct subtype41
ETMR: a tumor entity in its infancy40
Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS40
Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases38
C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?38
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study38
Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation37
Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo36
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers36
Selective vulnerability of inhibitory networks in multiple sclerosis36
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment36
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)35
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum35
Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation34
Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood–brain barrier in acute ischemic stroke34
Supratentorial ependymoma in childhood: more than just RELA or YAP34
Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases33
The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer’s disease33
Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease33
Making sense of missense variants in TTN-related congenital myopathies32
Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons32
A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer’s disease31
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations31
LATE-NC staging in routine neuropathologic diagnosis: an update31
Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features31
Intracellular calcium leak as a therapeutic target for RYR1-related myopathies30
Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders30
Seizure-mediated iron accumulation and dysregulated iron metabolism after status epilepticus and in temporal lobe epilepsy29
Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders29
Subgroup and subtype-specific outcomes in adult medulloblastoma29
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE129
DNA methylation age acceleration is associated with ALS age of onset and survival29
The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer’s disease28
Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizootic28
Vesicle trafficking and lipid metabolism in synucleinopathy28
Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy28
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort28
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia28
In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics27
Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt–Jakob disease27
BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy27
Cryo-EM structures of prion protein filaments from Gerstmann–Sträussler–Scheinker disease27
Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis27
Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease27
Synaptotagmin 13 is neuroprotective across motor neuron diseases26
Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy26
Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY)25
PTEN activation contributes to neuronal and synaptic engulfment by microglia in tauopathy24
CSF p-tau increase in response to Aβ-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles24
HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing24
Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids24
Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature23
Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ23
HIF-1α is involved in blood–brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis23
Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification23
MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease23
Heterogeneity in α-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia23
Epigenomic, genomic, and transcriptomic landscape of schwannomatosis23
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-4322
Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts22
Oligodendroglia heterogeneity in the human central nervous system21
Cryo-EM structures of amyloid-β filaments with the Arctic mutation (E22G) from human and mouse brains21
miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease21
Necrotic reshaping of the glioma microenvironment drives disease progression21
Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging21
APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology21
Tau immunotherapy is associated with glial responses in FTLD-tau21
Developmental malformations in Huntington disease: neuropathologic evidence of focal neuronal migration defects in a subset of adult brains21
Impairment of the mitochondrial one-carbon metabolism enzyme SHMT2 causes a novel brain and heart developmental syndrome21
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB120
Wolframin is a novel regulator of tau pathology and neurodegeneration20
The oncogenic fusion landscape in pediatric CNS neoplasms20
Histopathology of diffusion-weighted imaging-positive lesions in cerebral amyloid angiopathy20
Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes19
Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations19
Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies19
A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer’s disease19
ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer’s disease19
Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease18
The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment18
Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology18
Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is independently associated with dementia and strongly associated with arteriolosclerosis in the oldest-old18
DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner18
Complement deposition at the neuromuscular junction in seronegative myasthenia gravis18
Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity18
MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis18
Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns18
Multiomic elucidation of a coding 99-mer repeat-expansion skeletal muscle disease18
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling18
Retinal pathological features and proteome signatures of Alzheimer’s disease17
Neuronal spreading and plaque induction of intracellular Aβ and its disruption of Aβ homeostasis17
Biallelic mutations in NRROS cause an early onset lethal microgliopathy17
Association of probable REM sleep behavior disorder with pathology and years of contact sports play in chronic traumatic encephalopathy17
Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus–pericoerulear complex by three-dimensional imaging17
Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to ‘Polymorphous low-grade neuroepithelial tumor of the young’16
Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation16
TDP-43 interacts with pathological τ protein in Alzheimer’s disease16
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease16
Heterogeneity of white matter astrocytes in the human brain16
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis16
Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features16
Association of small vessel disease with tau pathology16
Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease16
Oligosarcomas, IDH-mutant are distinct and aggressive16
TREM2 expression in the brain and biological fluids in prion diseases16
EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma16
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types15
A novel ATXN1-DUX4 fusion expands the spectrum of ‘CIC-rearranged sarcoma’ of the CNS to include non-CIC alterations15
Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease15
Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut15
Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission15
Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients15
Intellectual disability: dendritic anomalies and emerging genetic perspectives15
Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer’s disease (AD) mouse model and is increased at early stage in sporadic AD brain15
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma15
Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum14
Genetics of synucleins in neurodegenerative diseases14
PSD-93 up-regulates the synaptic activity of corticotropin-releasing hormone neurons in the paraventricular nucleus in depression14
Alzheimer disease neuropathology in a patient previously treated with aducanumab14
TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury14
Environmental and host factors that contribute to prion strain evolution14
Consequences of variability in α-synuclein fibril structure on strain biology14
Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex13
A network of core and subtype-specific gene expression programs in myositis13
Evidence of disrupted rhombic lip development in the pathogenesis of Dandy–Walker malformation13
An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD13
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies13
Vagus nerve inflammation contributes to dysautonomia in COVID-1913
ATP10B and the risk for Parkinson’s disease13
Signature laminar distributions of pathology in frontotemporal lobar degeneration12
Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies12
Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma12
Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease12
Cross-regional homeostatic and reactive glial signatures in multiple sclerosis12
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 1312
The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma12
Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR812
Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions12
Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state12
Early white matter pathology in the fornix of the limbic system in Huntington disease12
Targeting fibroblast growth factor receptors to combat aggressive ependymoma12
Huntington’s disease brain-derived small RNAs recapitulate associated neuropathology in mice11
Dominant-acting CSF1R variants cause microglial depletion and altered astrocytic phenotype in zebrafish and adult-onset leukodystrophy11
rs4147929 variant minor allele increases ABCA7 gene expression and ABCA7 shows increased gene expression in Alzheimer’s disease patients compared with controls11
Antibodies to MOG in CSF only: pathological findings support the diagnostic value11
Molecular characterization of DICER1-mutated pituitary blastoma11
Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges11
Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations11
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas11
Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer’s disease neuropathologic change11
ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance11
Heteroplasmic mitochondrial DNA mutations in frontotemporal lobar degeneration11
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers11
Frequency and distribution of TAR DNA-binding protein 43 (TDP-43) pathology increase linearly with age in a large cohort of older adults with and without dementia11
Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma11
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype11
Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities10
α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders10
Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old10
Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies10
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma10
Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI10
DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival10
Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer’s disease10
Concussion leads to widespread axonal sodium channel loss and disruption of the node of Ranvier10
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 110
Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice10
Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis10
Oncostatin M triggers brain inflammation by compromising blood–brain barrier integrity10
Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease10
Brain pathologies are associated with both the rate and variability of declining motor function in older adults10
EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma10
Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo9
Fatal encephalitis caused by Newcastle disease virus in a child9
Histopathology of the cerebellar cortex in essential tremor and other neurodegenerative motor disorders: comparative analysis of 320 brains9
Strain diversity in neurodegenerative disease: an argument for a personalized medicine approach to diagnosis and treatment9
Amyotrophic lateral sclerosis is over-represented in two Huntington’s disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT gene expansion9
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas9
A recurrent homozygous ACTN2 variant associated with core myopathy8
Dipeptide repeat protein and TDP-43 pathology along the hypothalamic–pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases8
HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS8
Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis8
Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord8
DTYMK is essential for genome integrity and neuronal survival8
Phenotypic diversity in ALS and the role of poly-conformational protein misfolding8
DGCR8 and the six hit, three-step model of schwannomatosis8
Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer’s disease and Down syndrome8
Evidence of traumatic brain injury in headbutting bovids8
LRRK2 is reduced in Parkinson’s disease gut7
TREM2 risk variants are associated with atypical Alzheimer’s disease7
0.029953002929688